Latest Breaking News On - Katholisches klinikum - Page 1 : comparemela.com

Women with MS who stop taking natalizumab during pregnancy are at a significantly increased risk of relapse-related disability up to 1 year after delivery, new research shows.

Nordrhein westfalenKerstin hellwigKatholisches klinikumInnovation fund of the federal joint committeeUniversity of california san diegoTeva pharmaceuticalsGerman multiple sclerosisExpanded disability status scaleSevere relapse disability composite scoreProblem no matter when youMedscape medical newsJennifer gravesCalifornia san diegoPregnancy registryInnovation fundFederal joint committee